VenoStent
PrivateLast Round
Seed Round
May 1, 2026
Total Funding Raised
$32.45M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
VenoStent is a medical device company that develops bioabsorbable vascular wraps to improve outcomes for hemodialysis patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VenoStent Comparables
Compare VenoStent with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laminate Medical Technologies | 92% | |
| Phraxis, Inc. | 78% | |
| Vascudyne | 77% |
VenoStent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 1, 2026 | ||||
| Grant | Jun 27, 2024 | ||||
| Series A Extension | Jun 27, 2024 | ||||
| Series A | Jul 31, 2023 | ||||
| Seed | Feb 23, 2021 | ||||
SAFE | Jun 24, 2020 |
Key People
Founding team and executive leadership
VenoStent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Olima Ventures | Seed |
| Good Growth Capital | Series A, Series A Extension |
| IAG Capital Partners | Seed, Series A, Series A Extension |
| NIH RADx | Grant |
| Creative Ventures | Series A, Seed |
| SNR | Series A |
| Norwest Venture Partners | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 31% MoM, reaching 5.2K.
- Aug 2, 2026
Grew 15% QoQ, from 33 to 38 employees.
VenoStent Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VenoStent's valuation, stock price, and market status.
Is VenoStent a public or private company?
VenoStent is a private company.
What is the current stock price of VenoStent?
VenoStent is a private company with no public stock price. No recent secondary market data is available.
How much is VenoStent worth (valuation)?
Valuation information for VenoStent is not publicly available.
Can I buy VenoStent stock?
VenoStent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VenoStent's last funding round?
VenoStent's most recent funding round was Seed Round on May 1, 2026.
Who are the main investors in VenoStent?
Key investors in VenoStent include Good Growth Capital, IAG Capital Partners, Creative Ventures, Norwest Venture Partners, Texas Halo Fund.
Will VenoStent IPO soon?
No public IPO plans have been announced for VenoStent.
How can I track VenoStent secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VenoStent's secondary market activity and sign up for updates.